Why the study?
Does paeoniflorin improve nonalcoholic fatty liver disease and metabolic parameters in a high-fat diet mouse model?
Population
Mice with nonalcoholic fatty liver disease (NAFLD) induced by a high-fat diet
Design
Preclinical
Authors
Loading...
Hypothesis-generating in murine NAFLD; human trials needed before any clinical consideration.
Does paeoniflorin improve nonalcoholic fatty liver disease and metabolic parameters in a high-fat diet mouse model?
Paeoniflorin prevents the development of NAFLD and may reduce atherosclerosis risk through multiple intracellular signaling pathways in a mouse model.
Zhang et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: